OnCore Login

Sponsor-Investigators

Nancy Chan

BTCRC-BRE16-042

A Phase II Study of Pembrolizumab Plus Fulvestrant in Hormone Receptor Positive, HER-2 Negative Advanced/Metastatic Breast Cancer Patients: Big Ten Cancer Research Consortium BTCRC-BRE16-042
Status
Open to Accrual
Cancer Types
Breast
Locations
Fred & Pamela Buffett Cancer Center, Michigan State University, New York University Cancer Institute, Rutgers Cancer Institute of New Jersey, University of Wisconsin Carbone Cancer Center
Read more
  • 7676 Interactive Way, Suite 120, Indianapolis, IN 46278